{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:08:21Z","timestamp":1791900501362,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jid.2016.06.622","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T15:09:44Z","timestamp":1468681784000},"page":"2201-2210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"title":["Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid"],"prefix":"10.1016","volume":"136","author":[{"given":"Kentaro","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Natsuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.06.622_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0923-1811(00)00149-3","article-title":"Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"26","author":"Amo","year":"2001","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamadermatol.2013.1073","article-title":"A\u00a0case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors","volume":"149","author":"Aouidad","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","article-title":"Diabetes is related to cerebral infarction but not to AD pathology in older persons","volume":"67","author":"Arvanitakis","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jid.2016.06.622_bib4","first-page":"24","article-title":"Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature","volume":"8","author":"Attaway","year":"2014","journal-title":"J\u00a0Dermatol Case Rep"},{"key":"10.1016\/j.jid.2016.06.622_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/fcp.12083","article-title":"Bullous pemphigoid induced by vildagliptin: a report of three cases","volume":"29","author":"Bene","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jid.2016.06.622_bib8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.06.622_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib11","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2016.06.622_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2012.09.012","article-title":"Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay","volume":"68","author":"Fairley","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib14","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A\u00a0pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0738-081X(93)90159-A","article-title":"Drug-induced bullous pemphigoid","volume":"11","author":"Fellner","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrg758","article-title":"Getting under the skin of epidermal morphogenesis","volume":"3","author":"Fuchs","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jid.2016.06.622_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1523-1747.ep12616580","article-title":"Cloning and primary structural analysis of the\u00a0bullous pemphigoid autoantigen BP180","volume":"99","author":"Giudice","year":"1992","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib18","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2741\/2785","article-title":"Dipeptidyl peptidase IV (DPP IV\/CD26) is a cell-surface plasminogen receptor","volume":"13","author":"Gonzalez-Gronow","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.jid.2016.06.622_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ncl.2008.07.003","article-title":"Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors","volume":"26","author":"Grysiewicz","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jid.2016.06.622_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/jid.2008.424","article-title":"Plasmin plays a role in the in\u00a0vitro generation of the linear IgA dermatosis antigen LADB97","volume":"129","author":"Hofmann","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1172\/JCI116368","volume":"91","author":"Ishiko","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.06.622_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2015.02.009","article-title":"Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid","volume":"78","author":"Kamiya","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jid.2016.06.622_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2016.06.622_bib28","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A\u00a0passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.06.622_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/1523-1747.ep12319337","article-title":"The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane","volume":"109","author":"Masunaga","year":"1997","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02505245","article-title":"The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen","volume":"288","author":"Matsumura","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2016.06.622_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000443330","article-title":"Three cases of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors - one due to linagliptin","volume":"232","author":"Mendonca","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2016.06.622_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In\u00a0vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib35","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.4049\/jimmunol.1003402","article-title":"Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner","volume":"188","author":"Natsuga","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.06.622_bib36","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.0202a-7.x","article-title":"IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180","volume":"115","author":"Nie","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jdermsci.2013.12.001","article-title":"Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII","volume":"73","author":"Nishie","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib38","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.4049\/jimmunol.1001524","article-title":"Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid","volume":"185","author":"Nishie","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.06.622_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2016.06.622_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1523-1747.ep12518285","article-title":"Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid","volume":"81","author":"Oikarinen","year":"1983","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib41","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.2337\/dc11-0804","article-title":"Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases","volume":"34","author":"Pasmatzi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jid.2016.06.622_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2004.02401.x","article-title":"Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes","volume":"135","author":"Schmidt","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2016.06.622_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2016.06.622_bib45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0002-9440(10)64772-4","article-title":"The shed ectodomain of collagen XVII\/BP180 is targeted by autoantibodies in different blistering skin diseases","volume":"156","author":"Schumann","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2016.06.622_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.1998.tb00329.x","article-title":"New insights into the immunoultrastructural organization of cutaneous basement membrane zone molecules","volume":"7","author":"Shimizu","year":"1998","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2016.06.622_bib48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1172\/JCI114036","article-title":"Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases","volume":"83","author":"Stanley","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.06.622_bib49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archdermatol.2010.322","article-title":"The\u00a0association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study","volume":"146","author":"Taghipour","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jdermsci.2004.10.007","article-title":"Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid","volume":"37","author":"Tsuji-Abe","year":"2005","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1346-8138.2012.01562.x","article-title":"Unilateral bullous pemphigoid without erythema and eosinophil infiltration in a hemiplegic patient","volume":"39","author":"Tsuruta","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jid.2015.11.030","article-title":"Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180","volume":"136","author":"Wada","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.06.622_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2014.07.008","article-title":"Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180","volume":"76","author":"Yamauchi","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.06.622_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","article-title":"Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid","volume":"41","author":"Yoshida","year":"2006","journal-title":"J\u00a0Dermatol Sci"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16321005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16321005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:37:54Z","timestamp":1542929874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16321005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0022202X16321005"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.06.622","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726512256.793525850","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.06.622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}